Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 10/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30095447 | 1.00 | MAP3K5 (0.47) | MAP3K5EGLN1HDAC3HDAC1HDAC6 | |
| SCHEMBL28899150 | 0.92 | MAP3K5 (0.45) | MAP3K5EGLN1HDAC3HDAC1HDAC6 | |
| SCHEMBL28899167 | 0.86 | HDAC3 (0.47) | MAP3K5EGLN1HDAC3HDAC1HDAC6 | |
| SCHEMBL30095514 | 0.86 | HDAC3 (0.47) | MAP3K5EGLN1HDAC3HDAC1HDAC6 | |
| SCHEMBL30095505 | 0.83 | MAP3K5 (0.53) | MAP3K5TP53MAPT | |
| SCHEMBL28899151 | 0.83 | MAP3K5 (0.53) | MAP3K5TP53MAPT | |
| SCHEMBL28899152 | 0.79 | MAP3K5 (0.43) | MAP3K5TP53MAPT | |
| SCHEMBL30095517 | 0.79 | MAP3K5 (0.43) | MAP3K5TP53MAPT | |
| SCHEMBL28899169 | 0.79 | MAP3K5 (0.43) | MAP3K5HDAC3HDAC1HDAC6TP53 | |
| SCHEMBL30362848 | 0.75 | MAPT (0.42) | MAP3K5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109456308-B | Heterocyclic compounds as ASK inhibitors and their use | 南京圣和药业股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-109456308-A | Heterocyclic compound and its application as ASK inhibitor | 南京圣和药业股份有限公司 | 2019-03-12 | — | — | CN | disclosed |